Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.
Eligible Conditions
- Chronic Pain
- Active Cancer Treatment
- Cancer, Advanced
- Malignant Neoplasms
- Active Cancer
- Palliative Care
Treatment Effectiveness
Effectiveness Progress
Other trials for Chronic Pain
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: 6 Months
4 Weeks
Overall Intervention Adherence Rate
4 weeks
Acceptability Rate
6 Months
Study Accrual Rate
Study retention
6 Weeks
COMPREHENSIVE ENDPOINT
Trial Safety
Safety Progress
Other trials for Chronic Pain
Trial Design
1 Treatment Group
STAMP+CBT PILOT
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: STAMP+CBT application · No Placebo Group · N/A
STAMP+CBT PILOT
Behavioral
Experimental Group · 1 Intervention: STAMP+CBT application · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: Dana-Farber at Merrimack Valley · Methuen, MA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Chronic Pain
0 CompletedClinical Trials
Who is running the clinical trial?
National Palliative Care Research Center (NPCRC)UNKNOWN
1 Previous Clinical Trials
62 Total Patients Enrolled
Dana-Farber Cancer InstituteLead Sponsor
1,008 Previous Clinical Trials
393,031 Total Patients Enrolled
1 Trials studying Chronic Pain
47 Patients Enrolled for Chronic Pain
Desiree Azizoddin, PsyDPrincipal InvestigatorDana-Farber Cancer Institute
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have chronic pain related to cancer or treatment.
You have an active prescription for at least one opioid medication to treat your cancer pain.
You are willing to use an android device provided by the study team.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments